Does RISANKIZUMAB-RZAA Cause Muscular weakness? 165 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 165 reports of Muscular weakness have been filed in association with RISANKIZUMAB-RZAA. This represents 0.3% of all adverse event reports for RISANKIZUMAB-RZAA.
165
Reports of Muscular weakness with RISANKIZUMAB-RZAA
0.3%
of all RISANKIZUMAB-RZAA reports
3
Deaths
67
Hospitalizations
How Dangerous Is Muscular weakness From RISANKIZUMAB-RZAA?
Of the 165 reports, 3 (1.8%) resulted in death, 67 (40.6%) required hospitalization, and 2 (1.2%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 165 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Muscular weakness Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA